IP Library Granted Patent US 7,019,108
Granted Patent B2
US 7,019,108 · App. 09/872,165 · Granted Mar 28, 2006

Method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2

Assignee: University of Southern California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,019,108
App. No.
09/872,165
Granted
Mar 28, 2006
Kind
B2
Abstract

The present invention provides methods and compositions for inhibiting angiogenesis, tumor growth and treating disease states using a peptide that contains a specific amino acid sequence of matrix metalloproteinase 2 (MMP-2). In one embodiment, the invention provides a peptide, which comprises the amino acid sequence Ile-Phe-Ala-Gly-Asp-Lys-Phe-Trp-Arg, preferably flanked by cysteine residues at the amino and carboxy termini. Additionally, the invention provides compositions for inhibiting angiogenesis or tumor growth or for treating disease states comprising organic and non-peptidic mimetics based on the above amino acid sequence as well as optimized sequences flanking the region of MMP-2 within which the sequence lies. Also provided are methods for detecting angiogenesis, tumorous tissue, metastases, and tumor invasion into a tissue by contacting a composition of the invention with a tissue and methods for screening compositions of the invention.

Claims (7)

1. An isolated anti-angiogenic peptide comprising the sequence of SEQ ID NO: 2.

2. The peptide of claim 1 wherein said peptide inhibits angiogenesis.

3. The peptide of claim 1 wherein said peptide inhibits metastasis.

4. The peptide of claim 1 wherein said peptide inhibits an angiogenic disease.

5. The peptide of claim 4 wherein the disease is psoriasis, macular degeneration, a neurological disease, or restenosis in a tissue.

6. An isolated peptide consisting of the sequence in SEQ ID No: 1.

7. An peptide of The claim 1 consisting of SEQ ID No: 2.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 9, 2010
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024804/0990 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Feb 23, 2009
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022288/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2001
From: BROOKS, PETER C.; RODRIGUEZ, DOROTHY
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 012268/0452 →
Continuity (1)
Related Publication 20020182215A1 · Dec 5, 2002